Skip to content

Total Arterial Revascularization (TAR)

Comparison of Total Arterial Revascularization of Y-Graft Versus In-Situ Configuration Using Bilateral Internal Thoracic Arteries

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03753048
Enrollment
880
Registered
2018-11-26
Start date
2018-03-13
Completion date
2024-03-31
Last updated
2018-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass Grafting, Coronary Artery Disease

Keywords

Total Arterial Revascularization, Y-Graft, In-Situ, Coronary Artery Bypass Grafting

Brief summary

Total arterial revascularisation with in-situ confihuration of BITA is superior than y-graft in patients underwent CABG.

Detailed description

The main hypothesis of the trial is that in-situ configuration of bilateral internal thoracic arteries is superior than Y-graft configuration for MACCE (mortality, myocardial infarction, repeat revascularization, stroke) during mid-term follow-up in patients with CAD who is shedueled for CABG.

Interventions

PROCEDUREY-Graft

Y-Graft Configuration Using BITA. Surgery can be performed off-pump or on the CPB. Both internal thoracic arteries should be harvested in semi-sceletonized fashion. After the administration of 3 mg/kg i/v UFH, the left internal thoracic artery is cut off distally and the right internal thoracic artery is cut off proximally and distally. Then they anastomose the following way. Left internal thoracic artery should be anastomosed to the left anterior descending artery (LAD) at first. Secondly, distal part of the right internal thoracic artery should be anastomosed to the obtuse marginal artery. Finally, proximal part of the right internal thoracic artery is anastomosed to the left internal thoracic artery as Y-graft in the end to side fashion. If it is nessesary, the right coronary artery system can be bypassed by separate autoarterial (eg. radial artery) or autovenous graft with proximal anastomose to the aorta.

PROCEDUREIn-Situ

In-Situ Configuration Using BITA. Surgery can be performed off-pump or on the CPB. Both internal thoracic arteries should be harvested in semi-sceletonized fashion. After the administration of 3 mg/kg i/v UFH, both internal thoracic arteries are cut off distally. Then they anastomose the following way. Right internal thoracic artery should be anastomosed to the left anterior descending artery (LAD) at first. Secondly, left internal thoracic artery should be anastomosed to the obtuse marginal artery. If it is nessesary, the right coronary artery system can be bypassed by separate autoarterial (eg. radial artery) or autovenous graft with proximal anastomose to the aorta.

Sponsors

Kemerovo Cardiology Center
CollaboratorOTHER
Meshalkin Research Institute of Pathology of Circulation
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Coronary Artery Disease * Stable angina * The need for revascularization of anterior descending and obtuse margin arteries accoring to the 2018 ESC/EACTS Guidelines on myocardial revascularization * Informed Consent Form

Exclusion criteria

* The diameter of the target arteries is less than 1 mm * Stenosis of the subclavian arteries more than 60% * STEMI less than 3 month * Previous cardiac surgery * BMI \>35 * COPD with FEV1 \<60% * Concomitant pathology that requires simultaneous surgical treatment * Cancer with life expectancy less than 5 years

Design outcomes

Primary

MeasureTime frameDescription
Freedom from MACCE5 yearsComposite MACCE (mortality, myocardial infarction, repeated revascularization, stroke)

Secondary

MeasureTime frameDescription
Graft patency5 yearsGraft patency in 5 years
Quality of life (SF-36)5 yearsAssessment of the patient's quality of life by the Short Form-36 in 5 years
Treadmill stress test5 yearsNon-invasive diagnosis of myocardial ischemia

Countries

Russia

Contacts

Primary ContactDmitry A Sirota, MD
sirotad@yandex.ru+79132012140

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026